Skip to main content
. 2022 Oct 20;10:e14224. doi: 10.7717/peerj.14224

Table 2. Comparison of the clinical and laboratory characteristics between patient groups after PSM.

The table shows that there were significant differences in baseline RDW, serum albumin and PLR between the two groups after PSM.

Variables No-CA-AKI group (n = 100) CA-AKI group (n = 25) P value
Clinical Characteristics
Age (years) 71.5 (36.00, 89.00) 72 (40.00, 88.00) 0.793
Male [n (%)] 66 (66.00) 17 (68.00) 0.850
Diabetes [n (%)] 26 (26.00) 4 (16.00) 0.433
Hypertension [n (%)] 51 (51.00) 11 (44.00) 0.656
coronary heart disease [n (%)] 19 (19.00) 5 (20.00) 1.000
Smoking [n(%)] 43 (43.00) 11 (44.00) 1.000
Statins [n(%)] 45 (45.00) 7 (28.00) 0.173
ACEI/ARB [n(%)] 19 (19.00) 4 (16.00) 1.000
Total amount of contrast (ml, x ± s) 86.23 ± 17.48 85.93 ± 19.91 0.940
Laboratory characteristics
Baseline serum creatinine (µmol/L, M(1/4, 3/4)) 83.5 (66.0,113.3) 95.0 (85.00, 130.50) 0.020
Baseline eGFR (ml⋅ min symbol−1⋅ (1.73 m 2) symbol−1) 73.25 (52.65,87.52) 61.12 (47.73,74.44) 0.019
Hemoglobin (g/L) 126.0 (113.0, 137.0 ) 112.0 (93.0,138.5 ) 0.058
Red cell distribution width (%) 13.30 (12.70, 13.90) 15.10 (13.30, 16.35) <0.0001
Red blood cell count (×1012/L) 4.24 ± 0.62 4.12 ± 0.79 0.411
White blood cell count (×109/L) 8.10 (6.83, 10.30) 7.60 (5.35, 8.55) 0.053
Total serum protein (g/L, x ± s) 69.31 ± 8.12 68.46 ± 8.38 0.644
Albumin (g/L) 37.50 (34.90,40.53) 33.90 (30.80, 38.55 ) 0.005
Total cholesterol (mmol/L) 4.34 (3.75, 5.26) 3.92 (3.43, 5.37) 0.527
Triglyceride (mmol/L) 1.21 (0.85, 1.64) 1.31 (0.73, 1.69) 0.888
LDL-C (mmol/L) 2.51 (1.91, 3.21 ) 2.34 (1.93, 3.42 ) 0.672
HDL-C (mmol/L) 0.96 (0.82, 1.13 ) 0.94 (0.76, 1.06 ) 0.573
Uric acid (µmol/L) 350.0 (283.0, 421.0) 357.00 (289.8, 465.00) 0.375
Glucose (mmol/L) 5.60 (5.13, 6.60) 5.40 (4.70, 6.60) 0.222
NLR 2.55 (1.86,3.88) 3.42 (1.87,5.81) 0.121
PLR 111.73 (85.82,180.46) 148.72 (111.51,304.22) 0.009

Notes.

Abbreviations

CA-AKI
contrast-associated acute kidney injury
eGFR
estimated glomerular filtration rate
ACEI/ARB
angiotensin-converting enzyme inhibitor/angiotensin receptor blocker
LDL-C
high-density lipoprotein cholesterol
HDL-C
low-density lipoprotein cholesterol
NLR
neutrophil to lymphocyte ratio
PLR
platelet to lymphocyte ratio